D. Venyov

The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol

M. Maschan, G. Novichkova, L. Shelikhova, 2022, Pediatric Hematology/Oncology and Immunopathology.

Results of the use of cladribine in children with acute myeloid leukemia in the treatment according to the AML-MM-2006 protocol

M. Maschan, G. Novichkova, A. A. Maschan, 2021, Pediatric Hematology/Oncology and Immunopathology.

Lymphoma as a rare complication of severe combined immunodeficiency

A. Shcherbina, D. Balashov, D. Venyov, 2019, Pediatric Hematology/Oncology and Immunopathology.

Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia

G. Ovsyannikova, M. Maschan, G. Novichkova, 2022, Blood advances.

Potential value of high-throughput single-cell DNA sequencing of Juvenile myelomonocytic leukemia: report of two cases

Y. Olshanskaya, M. Maschan, D. Venyov, 2023, NPJ systems biology and applications.

Treatment results of children and adolescents with relapsed AML who were initially treated according to the AML-MM-2006 protocol

I. Kalinina, A. Maschan, M. Maschan, 2023, Russian journal of hematology and transfusiology.